Trials / Completed
CompletedNCT00977730
The Effect of Protandim on Non-alcoholic Steatohepatitis
The Effect of the Dietary Supplement Protandim on Non-Alcoholic Steatohepatitis: A Randomized, Double Blind, Placebo-Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of Protandim on the degree of liver injury after one year of supplementation. Protandim is a nutritional supplement composed of the following 5 botanical extracts: Bacopa Moniera extract, Milk Thistle extract, Ashwagandha powder, Green tea, and Turmeric extract. Protandim is commercially available and can be purchased without a prescription. Our findings could lead to a better understanding of the role of oxidative stress and antioxidant therapy in NASH and may ultimately help improve patient care. Hypothesis #1: Protandim will lead to a significant improvement in NAS compared to placebo. Hypothesis #2: Protandim will lead to a significant decrease in serum markers of oxidative stress and liver chemistry tests. Hypothesis #3: Protandim will lead to decreased levels of TNF- α compared to placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Protandim | 1 675 mg capsule Protandim PO/day vs. 1 sugar pill PO/day |
| DIETARY_SUPPLEMENT | Placebo | 1 675 mg capsule Protandim PO/day vs. 1 sugar pill PO/day |
Timeline
- Start date
- 2008-07-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2009-09-16
- Last updated
- 2013-02-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00977730. Inclusion in this directory is not an endorsement.